Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid Infusion

PHASE4RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 30, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
HealthyType 2 DiabetesObesity
Interventions
DRUG

Dextrose

Intravenous graded glucose infusion using 50% dextrose will commence at 1mg/kg/min and increase to 2 (0900), 4 (1000) and 8mg/kg/min (1100) every 60 minutes

DRUG

Clinisol 15%

Intravenous infusion 0.003ml/kg/min infused from 0 to 240 minutes

Trial Locations (1)

55905

RECRUITING

Mayo Clinic Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Mayo Clinic

OTHER

NCT05264727 - Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid Infusion | Biotech Hunter | Biotech Hunter